Comments
Loading...
Cardiol Therapeutics (CRDL) Forecast
NewsEarningsCardiol Therapeutics (CRDL) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestCardiol Therapeutics (NASDAQ:CRDL) Stock Quotes, Forecast and News Summary
Cardiol Therapeutics Stock (NASDAQ: CRDL) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Cardiol Therapeutics (CRDL) stock?
You can purchase shares of Cardiol Therapeutics (NASDAQ:CRDL) through any online brokerage.
Who are Cardiol Therapeutics (CRDL) competitors?
There are no as such competitors for Cardiol Therapeutics.
What is the forecast, or price target, for Cardiol Therapeutics (CRDL) stock?
Cardiol Therapeutics has a consensus price target of $7.50.
What is the current price for Cardiol Therapeutics (CRDL)?
The stock price for Cardiol Therapeutics (NASDAQ: CRDL) is $1.25 last updated February 21, 2025 at 10:34 AM EST.
Does Cardiol Therapeutics (CRDL) pay a dividend?
There are no upcoming dividends for Cardiol Therapeutics.
When is Cardiol Therapeutics (NASDAQ:CRDL) reporting earnings?
Cardiol Therapeutics’s Q1 earnings are confirmed for Tuesday, May 13, 2025.
Is Cardiol Therapeutics (CRDL) going to split?
There is no upcoming split for Cardiol Therapeutics.
What sector and industry does Cardiol Therapeutics (CRDL) operate in?
Cardiol Therapeutics is in the Healthcare sector and Drug Manufacturers—Specialty & Generic industry. They are listed on the NASDAQ.